| 2.94 0.24 (8.89%) | 11-04 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | |
|||
| Targets | 6-month : | 4.04 | 1-year : | 4.69 |
| Resists | First : | 3.46 | Second : | 4.01 |
| Pivot price | 2.92 |
|||
| Supports | First : | 2.56 | Second : | 2.13 |
| MAs | MA(5) : | 2.73 |
MA(20) : | 3.05 |
| MA(100) : | 2.39 |
MA(250) : | 0 | |
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 19.9 |
D(3) : | 12.5 |
| RSI | RSI(14): 48.4 |
|||
| 52-week | High : | 7.59 | Low : | 0.51 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ HIT ] has closed below upper band by 48.2%. Bollinger Bands are 5.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.74 - 2.75 | 2.75 - 2.77 |
| Low: | 2.57 - 2.58 | 2.58 - 2.59 |
| Close: | 2.68 - 2.7 | 2.7 - 2.72 |
Health In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small to medium sized employers. It also provides health intelligence (HI) card to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.
Mon, 03 Nov 2025
HIT - Health In Tech, Inc. Latest Stock News & Market Updates - Stock Titan
Mon, 03 Nov 2025
Health In Tech (NASDAQ: HIT) sets Nov. 10 results release; call at 5 p.m. ET - Stock Titan
Thu, 09 Oct 2025
Health In Tech (NASDAQ:HIT) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Sat, 20 Sep 2025
Health In Tech, Inc.'s (NASDAQ:HIT) CEO Tim Johnson is the most upbeat insider, and their holdings increased by 36% last week - simplywall.st
Mon, 11 Aug 2025
Health In Tech: Validating Its Growth With Solid Results - Seeking Alpha
Sat, 02 Aug 2025
With a 76% stake, Health In Tech, Inc. (NASDAQ:HIT) insiders have a lot riding on the company - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 45 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 70.4 (%) |
| Held by Institutions | 0.8 (%) |
| Shares Short | 134 (K) |
| Shares Short P.Month | 90 (K) |
| EPS | 0.01 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.28 |
| Profit Margin | 5 % |
| Operating Margin | 7.7 % |
| Return on Assets (ttm) | 5 % |
| Return on Equity (ttm) | 11.8 % |
| Qtrly Rev. Growth | 86.1 % |
| Gross Profit (p.s.) | 0.42 |
| Sales Per Share | 0.59 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 53.2 % |
| Operating Cash Flow | 4 (M) |
| Levered Free Cash Flow | 2 (M) |
| PE Ratio | 147 |
| PEG Ratio | 0 |
| Price to Book value | 10.13 |
| Price to Sales | 4.93 |
| Price to Cash Flow | 36.55 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |